Organization | T.C. Ordu Universitesi

T.C. Ordu Universitesi Report issue

Academic/Hospital Phase 4

Founded: Ordu Turkey (2006)

Organization Overview

First Clinical Trial

2013

NCT01938755

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Dr. Damla Torul | Ordu Ünivercity | Ordu Üniversitesi | Ordu University, Turkey | Scientific Researches Project Coordination Department of Ordu University | Sema BÜĞÜŞAN ORUÇ | Sevim ACARÖZ CANDAN | T.C. ORDU ÜNİVERSİTESİ

Active Ingredients

Drugs in Phase 4 Trials (9)

atropine (1 trial)

dexibuprofen (1 trial)

etomidate (amidate) (1 trial)

levobupivacaine (chirocaine) (1 trial)

neostigmine (bloxiverz) (2 trials)

propofol (diprivan) (1 trial)

sodium chloride (1 trial)

sugammadex (bridion) (2 trials)

tenoxicam (1 trial)

Drugs in Other Trials (3)

concentrated growth factor (1 trial)

platelet rich fibrin (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Nausea (Phase 4)

Postoperative Nausea and Vomiting (Phase 4)

Vomiting (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 14
# of Trial APIs: 12